{"result": "(\"entity\"<|>FIBRAS<|>ORGANIZATION<|>Fibers with prebiotic effects that benefit immunity and aid in nutrient absorption)\n##\n(\"entity\"<|>FÓRMULAS POLIMÉRICAS<|>ORGANIZATION<|>Polymeric formulas containing complex macronutrients used in enteral nutrition)\n##\n(\"entity\"<|>MACRONUTRIENTES<|>ORGANIZATION<|>Macronutrients that are essential for nutrition, including carbohydrates, proteins, and fats)\n##\n(\"entity\"<|>ALMIDÓN DE MAÍZ<|>ORGANIZATION<|>Corn starch used as a carbohydrate source in enteral formulas)\n##\n(\"entity\"<|>MALTODextrina<|>ORGANIZATION<|>Maltodextrin, a carbohydrate used in enteral nutrition)\n##\n(\"entity\"<|>FRUCTOSA<|>ORGANIZATION<|>Fructose, a simple sugar used in enteral nutrition)\n##\n(\"entity\"<|>CASEÍNA HIDROLIZADA<|>ORGANIZATION<|>Hydrolyzed casein, a protein source in enteral formulas)\n##\n(\"entity\"<|>AISLADO DE PROTEÍNA DE SOJA<|>ORGANIZATION<|>Soy protein isolate used in enteral nutrition)\n##\n(\"entity\"<|>ÁCIDOS GRASOS<|>ORGANIZATION<|>Fatty acids used in enteral nutrition formulas)\n##\n(\"entity\"<|>FIBRA DIETÉTICA<|>ORGANIZATION<|>Dietary fiber added to enteral formulas to improve gastric emptying and stabilize glucose levels)\n##\n(\"relationship\"<|>FIBRAS<|>FÓRMULAS OLIGOMÉRICAS<|>Fibers are included in oligomeric formulas to enhance their nutritional benefits<|>5)\n##\n(\"relationship\"<|>FÓRMULAS POLIMÉRICAS<|>NUTRICIÓN ENTERAL<|>Polymeric formulas are another type of nutritional therapy used in enteral nutrition<|>7)\n##\n(\"relationship\"<|>MACRONUTRIENTES<|>FÓRMULAS OLIGOMÉRICAS<|>Oligomeric formulas contain hydrolyzed macronutrients for better absorption<|>8)\n##\n(\"relationship\"<|>ALMIDÓN DE MAÍZ<|>FÓRMULAS OLIGOMÉRICAS<|>Corn starch is a carbohydrate source in oligomeric formulas<|>6)\n##\n(\"relationship\"<|>MALTODextrina<|>FÓRMULAS OLIGOMÉRICAS<|>Maltodextrin is used as a carbohydrate in oligomeric formulas<|>6)\n##\n(\"relationship\"<|>FRUCTOSA<|>FÓRMULAS OLIGOMÉRICAS<|>Fructose is included in oligomeric formulas as a carbohydrate source<|>6)\n##\n(\"relationship\"<|>CASEÍNA HIDROLIZADA<|>FÓRMULAS OLIGOMÉRICAS<|>Hydrolyzed casein is a protein source in oligomeric formulas<|>6)\n##\n(\"relationship\"<|>AISLADO DE PROTEÍNA DE SOJA<|>FÓRMULAS OLIGOMÉRICAS<|>Soy protein isolate is used in oligomeric formulas<|>6)\n##\n(\"relationship\"<|>ÁCIDOS GRASOS<|>FÓRMULAS OLIGOMÉRICAS<|>Fatty acids are included in oligomeric formulas for nutritional balance<|>6)\n##\n(\"relationship\"<|>FIBRA DIETÉTICA<|>FÓRMULAS OLIGOMÉRICAS<|>Dietary fiber is added to oligomeric formulas to improve digestion<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: rmulas pueden contener fibras con efecto prebiótico (fructooligosacáridos, oligofructosa e inulina) que tienen beneficios sobre la inmunidad (MALT) y facilitan la absorción. El fin de la utilización de estos preparados es la prevención del estreñimiento o la regularización de las diarreas, en el caso de preparados con un 100% de fibra soluble.\n\n### 3.2. Fórmulas oligoméricas\n\nLas fórmulas oligoméricas son aquellas que contienen los macronutrientes hidrolizados. Los nutrientes que se utilizan son hidrolizados de almidón de maíz, maltodextrina o fructosa en el caso de los carbohidratos; las proteínas se encuentran como aminoácidos y dipéptidos o tripéptidos (caseína hidrolizada o aislado de proteína de soja); y las grasas ésteres de ácidos grasos o ácidos grasos de cadena media.\n\n| Tabla 2. Clasificación de las fórmulas de nutrición enteral. |\n|-------------------------------------------------------------|\n| CRITERIO PRINCIPAL |\n| Complejidad macronutrientes |\n| Poliméricas (Macronutrientes complejos) | Oligoméricas (Macronutrientes) |\n| CRITERIO SECUNDARIO |\n| Concentración proteínas (% valor calórico total) |\n| Normoproteicas (< 18% VCT) | Hiperproteicas (> 18% VCT) |\n| CRITERIO ACCESORIO |\n| Densidad calórica |\n| Hipocalóricas: < 0,8 kcal/ml/día |\n| Normocalóricas: 0,8-1,2 kcal/ml/día |\n| Hipercalóricas: > 1,2 kcal/ml/día |\n| Contenido en fibra |\n| Con fibra |\n| Sin fibra |\n| FÓRMULAS ESPECÍFICAS |\n---\nTema 46. Nutrición enteral: concepto, indicación, fórmulas, seguimiento y complicaciones 737\n\nEl objetivo de estos productos es optimizar al máximo la asimilación de los nutrientes para aquellos pacientes que tienen alteraciones graves de la absorción.\n\nNo existe mucha evidencia sobre la utilización de estas fórmulas en comparación con las poliméricas. En general, se observa tolerancia similar entre ambos tipos de fórmulas17, 18 y la ESPEN no recomienda su uso rutinario en la enfermedad de Crohn, la colitis ulcerosa o el síndrome de intestino corto19. Por tanto, es necesario seleccionar estas fórmulas con cautela, porque a pesar de presentar nutrientes ya «digeridos», la elevada osmolaridad de las mismas puede acelerar el tránsito y empeorar la tolerancia.\n\n### 3.3. Fórmulas específicas\n\nLas fórmulas específicas son aquellas con cambios en la proporción de macronutrientes y/o con cambios en los tipos de macronutrientes principales, que están dirigidas a influir sobre la evolución y pronóstico en algunos de los aspectos de la enfermedad en la que se utilizan.\n\nLas principales fórmulas específicas para enfermedad son:\n\n- Fórmulas para diabéticos o intolerantes a la glucosa: Su principal efecto es controlar el ascenso de la glucosa postprandial utilizando nutrientes con un bajo índice glucémico. Esta situación debería asociarse a un mejor control glucémico. Aunque existen multitud de fórmulas para diabéticos en el mercado, la mayor parte de ellas tienen unas características comunes: utilizan hidratos de carbono naturales o sintéticos con bajo índice glucémico; existe un descenso de la proporción de hidratos de carbono y un aumento del porcentaje de proteínas y grasas; y se añade fibra dietética que enlentece el vaciado gástrico y estabiliza la variabilidad glucémica. Por otra parte, estos productos suelen tener un incremento de ácidos grasos monoinsaturados y antioxidantes que podrían mejorar el metabolismo oxidativo e influir sobre las complicaciones de la diabetes.\n  No existe todavía un posicionamiento claro al respecto de este tipo de fórmulas dada la carencia de evidencia consistente20.\n\n- Fórmulas para el paciente con patología renal: Estos preparados enterales tienen como principal característica la restricción hídrica, por tanto, son hipercalóricas. Asimismo tienen una restricción en iones, especialmente potasio y fósforo, además de una modificación de la concentración de proteínas. Estas fórmulas se utilizan típicamente en la enfermedad renal crónica en fases avanzadas. Las diferencias principales en la concentración de macro y micronutrientes viene dada en función de si el paciente se encuentra en prediálisis, diálisis peritoneal o hemodiálisis, ya que la carga de nutrientes es diferente. En el paciente en hemodiálisis se busca un contenido proteico y potasio\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional therapy aimed at optimizing nutrient absorption for patients with severe absorption disorders)\n##\n(\"entity\"<|>FÓRMULAS OLIGOMÉRICAS<|>ORGANIZATION<|>Oligomeric formulas containing hydrolyzed macronutrients used in enteral nutrition)\n##\n(\"entity\"<|>FÓRMULAS ESPECÍFICAS<|>ORGANIZATION<|>Specific formulas designed to influence the evolution and prognosis of certain diseases)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>A condition for which specific enteral formulas are developed to control postprandial glucose levels)\n##\n(\"entity\"<|>ENFERMEDAD RENAL CRÓNICA<|>EVENT<|>Chronic kidney disease for which enteral formulas are modified to restrict fluid and certain ions)\n##\n(\"relationship\"<|>FÓRMULAS OLIGOMÉRICAS<|>NUTRICIÓN ENTERAL<|>Oligomeric formulas are a type of nutritional therapy used in enteral nutrition<|>7)\n##\n(\"relationship\"<|>FÓRMULAS ESPECÍFICAS<|>NUTRICIÓN ENTERAL<|>Specific formulas are a category within nutritional therapy aimed at specific health conditions<|>7)\n##\n(\"relationship\"<|>DIABETES<|>FÓRMULAS ESPECÍFICAS<|>Specific formulas are developed for managing diabetes<|>6)\n##\n(\"relationship\"<|>ENFERMEDAD RENAL CRÓNICA<|>FÓRMULAS ESPECÍFICAS<|>Specific formulas are tailored for patients with chronic kidney disease<|>6)\n<|COMPLETE|>"}]}